Literature DB >> 16751006

Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE.

Joshua A Boyce1.   

Abstract

A case of a girl who presented at age 12 years with idiopathic cold urticaria is described. Her reactions to the cold became progressively more severe over a period of approximately 2 years, despite therapy with H1 antagonists and a type 1 receptor for cysteinyl leukotrienes receptor antagonist. She began to experience systemic symptoms on immersion in ocean water. She was atopic and had moderate persistent asthma. A trial of anti-IgE resulted in complete resolution of her urticaria and its associated manifestations. These findings should prompt a reexamination of the potential pathogenetic role played by IgE and its high-affinity receptor on mast cells in idiopathic cold urticaria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751006     DOI: 10.1016/j.jaci.2006.04.003

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  31 in total

Review 1.  Review of Physical Urticarias and Testing Methods.

Authors:  Mario Sánchez-Borges; Luis González-Aveledo; Fernan Caballero-Fonseca; Arnaldo Capriles-Hulett
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

Review 2.  Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease.

Authors:  Clifton O Bingham
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

3.  Cold-induced urticaria: challenges in diagnosis and management.

Authors:  Elana Fay Hochstadter; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2013-07-08

Review 4.  What to do with refractory urticaria patients.

Authors:  Allen P Kaplan
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

5.  Modern approaches to the diagnosis and treatment of cold contact urticaria.

Authors:  Karoline Krause; Torsten Zuberbier; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

Review 6.  Biologic agents in the treatment of urticaria.

Authors:  Allen P Kaplan
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

7.  Clinical impact of omalizumab in refractory chronic urticaria: One centre experience.

Authors:  Diana Deleanu; Irena Nedelea; Carina Petricau; Poliana Leru; Dinu Dumitrascu; Adriana Muntean
Journal:  Exp Ther Med       Date:  2019-10-24       Impact factor: 2.447

8.  Examination of the role of TRPM8 in human mast cell activation and its relevance to the etiology of cold-induced urticaria.

Authors:  Nevenka Medic; Avanti Desai; Hirsh Komarow; Lauranell H Burch; Geethani Bandara; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Cell Calcium       Date:  2011-09-08       Impact factor: 6.817

Review 9.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

Review 10.  Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.

Authors:  Christian Vestergaard; Mette Deleuran
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.